A Single-arm, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Cadonilimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Cadonilimab (Primary) ; Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Apr 2024 Status has been changed to completed.
- 01 Apr 2024 Results published in the Oral Oncology
- 13 Jun 2023 New trial record